Breaking News
2 days ago
Simantini Singh Deo
Avalyn Pharma appoints former Blueprint Medicines CEO Kate Haviland to its board to support growth of inhaled therapies for pulmonary fibrosis.
Simantini Singh Deo
Galapagos appoints Tania Philipp as CHRO, adding nearly 30 years of HR leadership in life sciences to its executive team.
Simantini Singh Deo
Invivyd appoints Michael Mina, M.D., Ph.D., as CMO to accelerate its infectious disease prevention pipeline.
Simantini Singh Deo
FDA clears Kestrel’s KRAS inhibitor KST-6051 for Phase 1 testing in advanced solid tumors.
Simantini Singh Deo